Clinical Trial News and Research

RSS

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Donepezil may have short-term benefit for mild cognitive impairment

People with mild cognitive impairment (MCI) taking the drug donepezil were at reduced risk of progressing to Alzheimer's disease (AD) for the first 18 months of a 3-year study when compared with their counterparts on placebo

21 Jul 2004

Clinical study compares treatments in early Parkinson's disease

University of Tennessee Health Science Center professor and vice chair of the Department of Neurology, Ronald F. Pfeiffer, M.D., has been an investigator with The Parkinson Study Group (PSG), which recently reported four-year results of a major long-term, multi-center clinical trial.

21 Jul 2004

Australian collaboration to produce cancer immunotherapy vaccines

A Brisbane based biomedical company, Tissue Therapies Limited (TIS) and the Queensland Institute of Medical Research (QIMR) have agreed on the terms of a new collaboration aimed at developing Tissue Therapies' VitroGro® cell growth technology as a platform to produce cancer immunotherapy vaccines.

21 Jul 2004

A new online and searchable European register of clinical trials in children

A new online and searchable European register of clinical trials in children, which has been developed in collaboration with academics at The University of Nottingham and will make the practice of paediatric medicine safer and more effective, has recently been launched.

19 Jul 2004

HHS recognizes obesity as a major public health problem

The HHS has announced a new Medicare coverage policy that would remove barriers to covering anti-obesity interventions if scientific and medical evidence demonstrate their effectiveness in improving Medicare beneficiaries' health outcomes.

17 Jul 2004

Results from clinical trial of TA-NIC, therapeutic vaccine for the treatment of nicotine addiction

Xenova Group has announced initial results from the second clinical trial of TA-NIC, the Company's therapeutic vaccine being developed for the treatment of nicotine addiction.

17 Jul 2004

Expansion of clinical trial of an experimental West Nile virus (WNV) treatment

The National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, has expanded its clinical trial of an experimental West Nile virus (WNV) treatment to about 60 sites throughout the United States and Canada.

15 Jul 2004

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Researchers seeking to direct cancer-killing immune cells against the deadliest brain tumors have three new targets that show promise in laboratory studies and in a Phase I patient trial, according to two articles in the July 15 issue of the journal Cancer Research.

15 Jul 2004

Strategic analysis of the breast cancer therapeutics pipeline

Strategic partnerships between the pharmaceuticals industry and the biotechnology sector are making breast cancer therapeutics one of the most dynamic segments in the overall oncology market.

15 Jul 2004

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).

12 Jul 2004

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Aids is one of the principal causes of infant mortality in many developing countries. Viral transmission takes place during pregnancy (in utero), at the moment of childbirth or even during breastfeeding.

10 Jul 2004

Evidence that new anti-inflammatory drug may sensitize leukemia, and breast and lung cancers to conventional chemotherapy

Ohio researchers have used a recently developed anti-inflammatory drug as a starting point to construct a possible new, targeted anti-cancer agent.

10 Jul 2004

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Myriad Genetics has announced that it has been awarded a five-year, $14.2 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

10 Jul 2004

Chemoradioimmunotherapy for advanced breast cancer

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo- and radioresistant mechanisms was by presented by Dr John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital

8 Jul 2004

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration

7 Jul 2004

Combining targeted immunotherapy with chemotherapy and radiation therapy to successfully kill metastatic tumour cells

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital

7 Jul 2004

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources.

3 Jul 2004

Drop in systolic blood pressure may indicate imminent likelihood of Alzheimer’s disease or dementia

Journal of the American Heart Association reports that a significant drop in systolic blood pressure may indicate imminent likelihood of Alzheimer’s disease or dementia in some elderly people.

2 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

Clinical Trial News and Research

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Donepezil may have short-term benefit for mild cognitive impairment

Clinical study compares treatments in early Parkinson's disease

Australian collaboration to produce cancer immunotherapy vaccines

A new online and searchable European register of clinical trials in children

HHS recognizes obesity as a major public health problem

Results from clinical trial of TA-NIC, therapeutic vaccine for the treatment of nicotine addiction

Expansion of clinical trial of an experimental West Nile virus (WNV) treatment

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Strategic analysis of the breast cancer therapeutics pipeline

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Evidence that new anti-inflammatory drug may sensitize leukemia, and breast and lung cancers to conventional chemotherapy

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Chemoradioimmunotherapy for advanced breast cancer

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Combining targeted immunotherapy with chemotherapy and radiation therapy to successfully kill metastatic tumour cells

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Drop in systolic blood pressure may indicate imminent likelihood of Alzheimer’s disease or dementia

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News